The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1181
April 26, 2004
View Complete Issue         Table of Contents 2019 
New Indications for Modafinil (Provigil)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
New Indications for Modafinil (Provigil)
April 26, 2004 (Issue: 1181)
Modafinil (Provigil - Cephalon; Alertec - Draxis in Canada), first approved by the FDA in 1999 for treatment of excessive daytime sleepiness associated with narcolepsy (Medical Letter 1999; 41:30), has now also been approved for treatment of patients...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: New Indications for Modafinil (Provigil)
Article code: 1181b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.